GENENTECH INC

Biopharma

DC, USLatest filing Jan 20, 2026In-house team

$10.4M

Reported spend

Budget/Appropriations leads by disclosed activity

Filings

Most recent on Jan 20, 2026

Firms engaged

GENENTECH, INC leads by reported spend

AI Industry Profile

Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.

ApprovedSource: ai

Confidence

95%

Dominant share

100%

Industry count

Biopharma

100%

Client is Genentech Inc., a well-known biotechnology/pharmaceutical company with multiple filings on drug development, FDA regulation, biosimilars, 340B, patent/IP, and drug pricing — consistent with the biopharma sector. Filings appear to be on the company's own behalf.

Reported Spend Over Time

Annual totals based on disclosed filing amounts.

2025

$8.6M3 filings

2026

$1.9M1 filings

What They're Lobbying On

Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.

Budget/Appropriations

BUD

4 mentions4 filingsLatest Jan 20, 2026

$1M

apportioned spend

HOUSE OF REPRESENTATIVES4SENATE4

Copyright/Patent/Trademark

Top Firms

The lobbying registrants handling this client, ranked by disclosed filing amounts.

GENENTECH, INC

Biopharma

4 filingsLatest Jan 20, 2026

$10.4M

Top Lobbyists

Lobbyists are ranked by appearances and an equal share of each filing's reported amount.

Recent Filings

The latest disclosures for this client.

GENENTECH, INC

2025 fourth quarter10 issues15 lobbyists

Medicare/MedicaidTaxation/Internal Revenue CodeTrade (domestic/foreign)

$1.9M

Jan 20, 2026

GENENTECH INC

AI Industry Profile

Reported Spend Over Time

What They're Lobbying On

Budget/Appropriations

Copyright/Patent/Trademark

Top Firms

Top Lobbyists

Recent Filings

Government Touchpoints

Attributed Recipients

Health Issues

Immigration

Manufacturing

Medical/Disease Research/Clinical Labs

Medicare/Medicaid

Pharmacy